# Leveraging Roundtrip, the single touchpoint for medical transportation, to eliminate transportation as a barrier to care for specialized patient populations such as those with opioid use disorder.

> **NIH NIH R43** · RIDE ROUNDTRIP, INC. · 2020 · $252,131

## Abstract

ABSTRACT
Roundtrip’s transportation software platform is a turnkey solution that addresses transportation as a social
determinant of health by offering a single touchpoint for any healthcare organization to coordinate all levels of
non-emergency transportation (rideshare, medical sedan, wheelchair van, non-emergency ambulance) for
specialized patient populations. Given the increasingly strong correlation between transportation, lack of
healthcare access, and patient no-shows to medical care, this project aims to study the effect of providing
subsidized rides for patients afflicted by opioid use disorder (OUD) or drug use that screen positive for a
transportation need. Roundtrip is focused on removing transportation as a barrier to access care, especially
as it pertains to substance and drug use. Roundtrip is currently partnered with some of the most reputed
national healthcare brands in the US across 20 states, including Geisinger, Johns Hopkins, the NIH, and
large behavioral health systems like Aurora Behavioral, moving patients daily that need various forms of
medical care including drug addiction and associated behavioral health issues related to opioid use. This
project seeks to measure the impact of access to timely transportation on overall clinical outcomes for the
aforementioned group of pre-identified patients, allowing partnered healthcare providers to effectively
administer medical care and prescribe medication-assisted treatment to those in need. We will determine if
the Roundtrip platform is an appropriate, scalable mechanism to promote an increased adoption of drug
treatment programs that have had well-documented success in reducing overall drug use by alleviating the
burden of transportation and the associated logistical challenges of such programs. Thus, we look to create a
scalable and data-driven mechanism that expands access to medical care for those affected by OUD and/or
drug use, with the goal of demonstrating a viable and replicable model that can be applied in communities
across the country.

## Key facts

- **NIH application ID:** 10013780
- **Project number:** 1R43DA051263-01
- **Recipient organization:** RIDE ROUNDTRIP, INC.
- **Principal Investigator:** Brendan McNiff
- **Activity code:** R43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $252,131
- **Award type:** 1
- **Project period:** 2020-04-01 → 2021-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10013780

## Citation

> US National Institutes of Health, RePORTER application 10013780, Leveraging Roundtrip, the single touchpoint for medical transportation, to eliminate transportation as a barrier to care for specialized patient populations such as those with opioid use disorder. (1R43DA051263-01). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10013780. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*